Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
3BBLACKBIO.BOthis company3B BlackBio Dx Ltd	₹1,288.35	16.05×	2.89×	6.61×	14.8×	21.4%	54.2%	36.4%	41.3%	18.1%	11.8%	2.9%	0.01×	-1.72×	217.84×	5.27×	0.4%	—	—	2	C+
ASPIRA.BOAspira Pathlab & Diagnostics Limited	₹126.95	1,117×	4.68×	2.29×	40.57×	-50.8%	35.3%	-0.3%	0.2%	0.4%	-0.5%	1.9%	0.27×	1.41×	-0.19×	1.43×	0.0%	2	—	1	C-
KRSNAA.NSKrsnaa Diagnostics Limited	₹493.60	16.62×	1.72×	2.18×	8.58×	-320.3%	39.0%	15.7%	13.1%	10.3%	5.9%	-5.6%	0.55×	1.98×	3.53×	2.68×	0.5%	3	—	2	B-
LALPATHLAB.NSDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
MOMOLBIO.BOMolbio Diagnostics Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
THYROCARE.NSThyrocare Technologies Limited	₹485.30	34.04×	9.48×	6.69×	20.95×	-16.7%	37.4%	25.0%	19.7%	27.8%	24.4%	3.5%	0.09×	0.05×	73.89×	3.39×	2.7%	5	29.38	3	B+
Peer median	—	38.71×	6.71×	4.49×	23.28×	-33.7%	38.2%	19.1%	15.7%	15.2%	11.4%	2.2%	0.18×	0.73×	15.38×	3.04×	0.8%	4	29.38	2	—